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Impaired utero-placental perfusion is a well-known feature of early preeclampsia and is
associated with placental hypoxia and oxidative stress. Although aberrations at the level of
the mitochondrion have been implicated in PE pathophysiology, whether or not hypoxia-
induced mitochondrial abnormalities contribute to placental oxidative stress is unknown.
Methods
We explored whether abnormalities in mitochondrial metabolism contribute to hypoxia-
induced placental oxidative stress by using both healthy term placentae as well as a tropho-
blast cell line (BeWo cells) exposed to hypoxia. Furthermore, we explored the therapeutic
potential of the antioxidants MitoQ and quercetin in preventing hypoxia-induced placental
oxidative stress.
Results
Both in placental explants as well as BeWo cells, hypoxia resulted in reductions in mitochon-
drial content, decreased abundance of key molecules involved in the electron transport
chain and increased expression and activity of glycolytic enzymes. Furthermore, expression
levels of key regulators of mitochondrial biogenesis were decreased while the abundance of
constituents of the mitophagy, autophagy and mitochondrial fission machinery was
increased in response to hypoxia. In addition, placental hypoxia was associated with
increased oxidative stress, inflammation, and apoptosis. Moreover, experiments with MitoQ
revealed that hypoxia-induced reactive oxygen species originated from the mitochondria in
the trophoblasts.
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Discussion
This study is the first to demonstrate that placental hypoxia is associated with mitochondrial-
generated reactive oxygen species and significant alterations in the molecular pathways
controlling mitochondrial content and function. Furthermore, our data indicate that targeting
mitochondrial oxidative stress may have therapeutic benefit in the management of patholo-
gies related to placental hypoxia.
Introduction
Preeclampsia (PE) is a progressive multisystem pregnancy disorder that affects 2% to 8% of all
pregnancies [1]. PE is mainly characterized by new onset of hypertension and proteinuria,
caused by placental dysfunction. Although systemic pathological changes usually resolve fol-
lowing delivery of the placenta, it still predisposes mothers to cardiovascular, renal, and chori-
onic hypertensive disease in later life [1, 2]. Currently, there is no treatment and management
of PE predominantly involves stabilization of the mother and fetus with timely delivery to pre-
vent deterioration of the condition and subsequently limit morbidity and mortality as a result
of the disorder [2].
Although the pathogenesis of PE remains poorly understood, the current paradigm revolves
around oxidative stress in the trophoblast, the cell type that forms the epithelial lining of the
placental villi that is in direct contact with the maternal blood [3, 4]. Oxidative stress has been
shown to induce apoptosis in trophoblasts, accelerate trophoblast turn-over and promote
excessive release of placental cytotoxic factors including e.g. pro-inflammatory cytokines and
vasoactive compounds in the maternal circulatory system [5]. These cytotoxic factors subse-
quently drive PE-like symptoms including endothelial dysfunction, systemic hypertension and
end-organ hypo-perfusion [5, 6]. Different stressors can lead to perturbation of placental
endocrine actions of which the predominant one in PE is utero-placental malperfusion sec-
ondary to abnormal remodeling of the uterine spiral arteries [7, 8].
Disturbed delivery of blood, causing local hypoxia, is known to cause damage to the mito-
chondrial electron transport chain (ETC) which, as the ETC is the main site for intracellular
oxygen consumption in the cell, can lead to increased production of reactive oxygen species
(ROS) [2, 5]. Interestingly, recent evidence suggests abnormalities at the level of the mitochon-
drion in PE-complicated placentae [9]. However, whether or not hypoxia triggers these abnor-
malities and if this is linked to the development of oxidative stress in the placenta remains
unclear.
Key mechanisms controlling mitochondrial function and content include biogenesis of
new organelles (mitochondrial biogenesis), selective autophagy-mediated degradation of mito-
chondria (mitophagy) as well as mitochondrial fusion and fission events [10, 11]. Mitochon-
drial biogenesis is essentially controlled by the peroxisome proliferator-activated receptor
(PPAR) gamma coactivator 1 (PGC-1) molecules that co-activate different nuclear proteins
with transcriptional activity such as estrogen-related receptors (ERRs), PPARs, and nuclear
respiratory factor 1/2α (NRF-1/2α), and mitochondrial transcription factor A (Tfam). These
proteins collectively drive the expression of mitochondrial proteins and replication of mito-
chondrial DNA (mtDNA) [12]. Mitophagy can be divided into receptor-mediated and ubiqui-
tin-mediated mitophagy. During receptor-mediated mitophagy, mitochondrial-based receptor
proteins e.g. FUND14 domain containing 1 (FUNDC1), BCL2/adenovirus E1B 19 kDa pro-
tein-interacting protein 3 (BNIP3) or BNIP3 like (BNIP3L), are activated. Subsequently, these
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activated receptor proteins recruit and bind a mammalian homologue of yeast autophagy-
related protein 8, including microtubule-associated protein 1 light chain 3 beta (LC3B) and
gamma-aminobutyric acid type A receptor associated protein like 1 (GABARAPL1) and so
predestines the organelle for authophagic degradation. The ubiquitin-mediated mitophagy
pathway is initiated by accumulation of PTEN induced putative kinase 1 (PINK1) on the mito-
chondrial membrane, where they recruit E3 ubiquitin-protein ligase Parkin (PARK2) and/or
several autophagy receptors (e.g. optineurin (OPTN)). When activated, PARK2 is able to ubi-
quitinate several different mitochondrial substrates, including mitofusin 1 (Mfn1) and Mfn2,
which in turn recruit the LIR-containing autophagy adaptor protein sequestome-1 (SQSTM1)
and LC3B resulting in degradation of the organelle.
Unraveling the relationship between hypoxia, the regulatory pathways controlling mito-
chondrial content and function, and oxidative stress in the trophoblast will enhance our
insight into the complex pathogenesis of PE and may pave the way for new treatment modali-
ties. Therefore, in this study, we exposed placental villous explants from non-complicated
pregnancies as well as a trophoblast cell line (BeWo cells) to hypoxia and comprehensively
assessed multiple indices of mitochondrial health, cellular oxidative stress, and antioxidant sys-
tems. Parameters related to the molecular regulation of mitochondrial health included assess-
ment of transcript and protein abundance as well as activity levels of constituents of
mitochondrial metabolic pathways and key regulators of mitochondrial biogenesis, mitophagy,
and the mitochondrial fusion and fission machinery. In addition, the potential of the flavonoid
quercetin [13] as well as the mitochondrial-targeted antioxidant MitoQ to limit oxidative stress
in BeWo cells was investigated.
Materials and methods
Clinical subject characteristics
Human term (>38 weeks gestational age) placentae were collected from cesarean deliveries
performed by the Department of Obstetrics and Gynecology at the Maastricht University med-
ical Center+. For this study, three placentae were used. Exclusion criteria were hypertension
(pre-existing or onset during pregnancy) and/or proteinuria as defined by the International
Society for the study of Hypertension in Pregnancy (ISSHP). The local medical ethics commit-
tee Maastricht University Medical Center+ approved the procedures and all procedures on
placentae were performed in accordance with the guidelines for experiments on human mate-
rial (Maastricht University Medical Center+, Maastricht, the Netherlands; No. 16-4-047) by
which placental samples were either collected as part of a prospective study for which partici-
pants gave written and verbal consent or collected as “biological waste” from discarded tissue
if participants did not verbally object to this happening, as documented by the health care pro-
vider in their medical files.
Villous explant isolation
As described earlier by Vangrieken et al. [14], three placental villous explants from non-com-
plicated cesarean deliveries were processed directly after delivery. Villous explants were col-
lected from the central region of the placentae at the maternal side. The basal plate of the
specimens was removed and the remaining tissue was rinsed in a HEPES solution (NaCl 143.3
mM, KCl 4.7 mM, MgSO4 1.2 mM, KH2PO4 1.2 mM, CaCl2 2.5 mM, glucose 5.5 mM, and
HEPES 15 mM). Subsequently, per placenta, two villous explants of 30 g were collected and
transferred into a 200 ml pre-warmed (37˚C) HEPES buffer, kept in a warm water bath (37˚C)
and aerated under a standard culture condition (21% O2) or a hypoxic condition (1% O2) for 3
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h. Tissue was collected and snap-frozen in liquid nitrogen, crushed by a mortar while frozen
and stored at -80˚C until use.
Cell culture
BeWo cells, a trophoblast cell line (ECACC, Porton Down, Salisbury, UK, No 86082803) were
cultured according to the manufacture’s protocol. Briefly, BeWo cells were cultured in Ham’s
F12 (Kaighn’s) growth medium (Glutamine 2 mM and D-Glucose 7 mM, GIBCO, Carlsbad,
CA, USA) enriched with 10% (vol/vol) fetal bovine serum (FBS) (SIGMA, St. Louis, MO,
USA) and antibiotics (50 U/ml penicillin and 50 μg/ml streptomycin; both from GIBCO).
Cells were routinely maintained in 175-cm2 falcon flasks at pH 7.4 under 5% CO2 and 95%
humidity at 37˚C and passaged when reaching confluency of 70–80%. For enzyme activity
assays and RNA/DNA isolation, 24 h after cell seeding in 6-wells plates (3x105 cells/well in 2
ml growth medium), cells were cultured for 24 h under a normoxic (control) condition (21%
O2, /5% CO2) +/- quercetin (3 μM, Sigma, St. Louis, MO, USA) or MitoQ (mitoquinone mesy-
late) (1, 4 or 8 μM, MedChemExpress, New Jersey, USA) or a hypoxic condition (1% O2 /5%
CO2) +/- quercetin (3 μM) or MitoQ (1, 4 or 8 μM). For detection of intracellular ROS levels,
72 h after cell seeding, cells were cultured for 24 h in black and clear bottom-96-wells plates
(Costar/sigma Aldrich) (1.5x104 cells/well in 200 μl growth medium) under a normoxic (con-
trol) condition (21% O2, /5% CO2) +/- quercetin (3 μM) or MitoQ (1, 4 or 8 μM), or a hypoxic
condition (1% O2 /5% CO2) +/- quercetin (3 μM), MitoQ (1, 4 or 8 μM) or H2O2 (100 μl, posi-
tive control).
Villous explant and BeWo viability
Lactate dehydrogenase (LDH) activity, as an indicator of cell/tissue viability was measured in
supernatant of both the cultured villous explants isolated from all 3 placentae and BeWo cells
of the standard culture and the hypoxic condition using the cytotoxicity detection kit (Cat.
No.11644793001, Roche, Mannheim, Germany).
Preparation of the lysates
Approximately 40 mg of powdered placental tissue was homogenized for 10 sec at maximal
speed with a hand-held PRO Scientific Bio-Gen PRO200 homogenizer in 800 μl KPE lysis
buffer (13 mM KH2PO4, 68 mM K2HPO4, 9 mM EDTA, and 1% Triton X-100) for antioxidant
enzyme activity assays or in 800 μl SET buffer (250 mM sucrose, 2 mM EDTA, 10 mM Tris,
pH 7.4) for metabolic enzyme activity assays. For the generation of BeWo lysates, cells were
washed twice with pre-cooled 1X Hank’s balanced salt solution (HBSS), incubated for 15 min
on ice in 500 μl KPE lysis buffer or in 100 μl SET buffer and collected using a rubber police-
man. Subsequently, samples were homogenized for 10 sec at maximal speed with a handheld
PRO Scientific Bio-Gen PRO200 homogenizer. KPE homogenates were centrifuged at 20,000
x g for 10 min at 4˚C. Subsequently, lysates (300 μl) were stored at -80˚C for the assessment of
Trolox Equivalent Antioxidant Capacity (TEAC). The remaining lysate was mixed with 2.6%
bovine serum albumin (BSA) (1:1) and stored at -80˚C for the determination of glutathione
disulfide/glutathione (GSSG/GSH) levels. SET homogenates were snap-frozen in liquid nitro-
gen, defrosted, incubated on ice for 30 min and subsequently centrifuged at 20,000 x g for 2
min at 4˚C. 5% BSA was added to the lysate (1:4) and stored at -80˚C for the assessment of the
citrate synthase (CS), β-hydroxyacyl-CoA dehydrogenase (HADH) and phosphofructokinase
(PFK) activity. For preparation of the BeWo lysates for measuring L-Lactae, the manufactur-
er’s protocol (L-Lactate Assay kit colometric, ab65331, Abcam, Cambridge, Massachusetts,
USA) was followed. For DNA and RNA isolation, BeWo cells were washed twice with pre-
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cooled 1X HBSS, incubated for 15 min on ice in 500 μl Trizol reagent and further processed
according to the manufacturer’s protocol (Catalog Number 15596026 and 15596018, Invitro-
gen™, USA). For generation of whole-cell lysates (for western blot analysis), BeWo cells were
washed twice with pre-cooled 1X HBSS, incubated for 30 min on ice in 100 μl IP lysis buffer
(50 mM Tris, 150 mM NaCl, 10% glycerol, 0.5% Nonidet P40, 1 mM EDTA, 1 mM Na3VO4, 5
mM NaF, 10 mM β-glycerophasphate, 1 mM Na4O7P2, 1 mM DTT, 10 μg/μl leupeptin, 1%
apropeptin, 1 mM PMSF, pH 7.4) and collected using a rubber policeman. Subsequently, sam-
ples were homogenized for 20 sec at maximal speed using the homogenizer. Lysates were incu-
bated for 30 min on ice and centrifuged at 20,000 x g for 30 min at 4˚C. Lysates were aliquoted
(1 μg/μl) in Laemmli buffer (0.25 M Tris-HCl, 8% (w/v) SDS, 40% (v/v) glycerol, 0.4 M DTT,
0.04% (w/v) Bromphenol Blue, pH 6.8) and boiled for 5 min at 95˚C. Protein concentrations
of whole-cell lysates and enzyme activity lysates were determined using the PierceTM BCA Pro-
tein Assay kit according to the manufacturer’s protocol (Pierce Chemical Co., Rockford, IL).
Citrate synthase (CS) activity
As previously described (CS; EC 2.3.3.1) [15], a reaction mix was set up in 96 well plates in
duplicate containing 5 μl undiluted sample, 200 μl reagent containing Tris (100 mM), DNTB
(0.1 mM) and acetyl-coenzym A (0.3 mM). The reaction was started with 5 μl start reagent
containing oxaloacetic acid (25 mM). Enzyme activity was monitored at 412 nm (37˚C) and
corrected for total protein concentration.
β-hydroxyacyl-CoA dehydrogenase (HADH) activity
As previously described (HADH; EC 1.1.1.35) [16], a reaction mix was set up in a 96 well plate
in duplicate containing 10 μl undiluted sample, 100 μl reagent containing NADH (1.1 mM),
tetrapotassium pyrophosphate (100 mM). The reaction was started with 10 μl acetyl-coenzym
A (2.4 mM). Enzyme activity was kinetically-monitored at 340 nm (37˚C) and corrected for
total protein concentration.
Phosphofructokinase (PFK) activity
As previously described ((PFK, EC 2.7.1.11) [17], a reaction mix was set up in a 96 well plate in
duplicate containing 20 μl undiluted sample, 100 μl reagent containing Tris Base (49.6 mM),
MgCl2.6H2O (7.4 mM), KCl (3.2 mM), KCN (384.6 μM), ATP (3.0 mM), DTT (1.5 mM),
NADH (0.3 mM), aldolase (0.019 U), glycerol-3-phosphate dehydrogenase (0.019 U) and tri-
ose phosphate, isomerase (0.019 U), pH 8.0. The reaction was started with fructose-6-phos-
phate (35.9 mM) in Tris buffer (49.6 mM), pH 8.0. Enzyme activity was monitored at 340 nm
(37˚C) and corrected for total protein concentration.
L-Lactate assay
As instructed by the manufacturer’s protocol (L-Lactate Assay kit colometric, ab65331,
Abcam, Cambridge, Massachusetts, USA), the reaction was started by adding reaction mix to
the sample wells and incubated for 30 minutes. L-Lactate was measured at 450 nm (37˚C).
Quantitative real-time PCR
cDNA was synthesized from 400 ng RNA using the iScriptTM cDNA synthesis kit (Bio-Rad,
Laboratories, Hercules, CA, USA) according to the manufacturer’s protocol. 4.4 μl of 1:50
diluted cDNA was used for quantitative PCR amplification using target-specific primers (S1
Table) and 2X SensimixTM SYBER1 & Fluorescein mix (Bioline, Alphen aan de Rijn, the
PLOS ONE Placental mitochondria and hypoxia
PLOS ONE | https://doi.org/10.1371/journal.pone.0245155 January 12, 2021 5 / 26
Netherlands) on a LightCycler480 384-wells PCR machine (Roche, Almere, the Netherlands).
Specificity of PCR amplification was checked by melt curve analysis. Expression levels of genes
of interest were corrected using normalization factor calculated based on the expression of 2
different housekeeping genes (Cyclophilin A and RPL13A), which were found to be most stable
from a selection of 3 genes by using the GeNorm software (Primerdesign, Southamton, USA).
The list of primers can be found in S1 Table.
Mitochondrial DNA (mtDNA) copy number
An amount of 4.4 μl of 1:25 diluted DNA was used for qPCR as described above, using mito-
chondrial DNA (mtDNA, Cytochrome c oxidase subunit II (COXII)) and genomic DNA
(gDNA, Ribosomal Protein L13a (RPL13A))–specific primers (S1 Table). mtDNA/gDNA
ratio was determined by dividing the relative quantity of mtDNA by the relative quantity of
gDNA.
JC-10 mitochondrial membrane potential
Mitochondrial membrane potential was assessed as instructed by the manufacturer’s proto-
col (JC-10 assay kit, ab112134, Abcam, Cambridge, Massachusetts, USA) according to the
manufacturer’s protocol. Briefly, BeWo cells were plated overnight at 40,000 cells/well in a
96-well plate and subsequently cultured under a normoxic (control) condition (21% O2, /5%
CO2), or a hypoxic condition (1% O2 /5% CO2) for 24 h. Then JC-10 dye-loading solution
was added in incubated for 30 min (37˚C) and assay buffer was added. The fluorescent inten-
sities for both J-aggregates and monometric forms JC-10 were measured at 515 nm and 570
nm (37˚C).
Western blotting
As described earlier by Leermakers et al. [18], 10 μg of protein was run through a Criterion XT
4–12 or 12% Bis-Tris gel (Bio-Rad, Veenendaal, the Netherlands) in 1x MES running buffer
(Bio-Rad, Veenendaal, the Netherlands) at 100 volts, and was subsequently blotted on a Nitro-
cellulose membrane (Bio-Rad Laboratories B.V., Veenendaal, the Netherlands) by electroblot-
ting. At least two protein ladders were loaded on each gel (Precision Plus Protein™ All Blue
Standards #161–0373, Bio-Rad Laboratories, Veenendaal, the Netherlands). Membranes were
stained with 0.2% PonceauS in 1% acetic acid (Sigma-Aldrich, Zwijndrecht, the Netherlands)
for 5 min, washed with milliQ and imaged using the Amersham™ Imager 600 (GE Healthcare,
Eindhoven, the Netherlands) to quantify total protein content as a correction for gel-loading.
Membranes were blocked for 1 h with Tween20 Tris-buffered saline (TBST; 20 mM Tris, 137
mM NaCl, 0.1% (vol/vol) Tween20, pH 7.6) containing 3% (w/v) non-fat dry milk (Campina,
Eindhoven, the Netherlands), washed, and incubated overnight at 4˚C with a target-specific
primary antibody (Table 1) diluted 1:1,000–1:10,000 in TBST with 3% (w/v) BSA or non-fat
dry milk at 4˚C. Subsequently, membranes were washed and incubated with a HRP-conju-
gated secondary antibody (#BA-9200, #BA-1000, Vector Laboratories, Amsterdam, the Neth-
erlands), diluted 1:10,000 in 3% (w/v) non-fat dry milk in TBST for 1 h at room temperature.
Membranes were then washed, incubated for 5 min with 0.5x SuperSignal West PICO or 0.25x
West Femto Chemiluminescent Substrate (Thermo Scientific, Landsmeer, the Netherlands)
and imaged using the Amersham™ Imager 600. Original unaltered images were quantified with
Image Quant software (GE Healthcare, Eindhoven, the Netherlands). Measured protein quan-
tity was corrected for total protein content. Images included in the figures of this manuscript
have been adjusted for brightness and contrast equally throughout the picture.
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Glutathione disulfide/glutathione (GSSG/GSH) levels
The GSH-assay was performed for the determination of the levels of GSH + GSSG and GSSG
as described previously [21]. GSH (0.1–10 μM) and GSSG (0.1–5 μM) standards were prepared
in KPE buffer and 1.3% 5-sulfosalicylic acid. GSSG standards and samples were diluted 1:10
with neat 2-vinylpyridine, incubated and mixed for 1 h to form a stable complex with GSH,
preventing it from participating in the enzymatic recycling reaction with glutathione reduc-
tase. Reactions were set up in a 96 well plate and 50 μl of the sample was loaded in duplicate.
Reactions were initiated by adding 100 μl 0.8 mM NADPH/0.6 mM DTNB 1:1 and 4 U/ml
GSSG reductase to the samples. Color development of the samples and standards was recorded
kinetically for 3 min in 9 reads at 412 nM resulting in GSH + GSSG and GSH slope values.
Activity was corrected for protein content of the samples and expressed in nM/mg protein/
min.
Trolox Equivalent Antioxidant Capacity (TEAC)
The Trolox equivalent antioxidant capacity (TEAC value) is a measurement for total antioxi-
dant status, relating the free radical scavenging properties of a solution or a compound to that
of the synthetic antioxidant Trolox and was performed as described earlier [19]. Briefly, a 5
mM 2,2’-azino-bis(3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) solution was prepared in
145 mM sodium phosphate buffer (pH 7.4). Then, an ABTS•− solution was prepared by adding
10 μl 1/100 horseradish peroxidase (HRP) and 10 μl of 2 mM H2O2 solution and diluted in an
ABTS solution to a final absorbance of 0.70 ± 0.02 at 734 nm at 37˚C. Deproteinization of the
samples was performed by adding 10% trichloroacetic acid (TCA) (1:1) to the samples. For
Table 1. Antibodies used for western blot.
Target RRID Company Product number Dilution
HKII AB_2232946 Cell Signaling Technology Cat# 2867 1:1000
OXPHOS AB_2629281 MitoScience LLC Cat# MS604 1:1000
PGC-1α AB_10697773 Millipore Cat# 516557 1:1000
NRF1 AB_2154534 Abcam Cat# ab55744 1:1000
ERRα AB_1523580 Abcam Cat# ab76228 1:1000
Tfam AB_10682431 Millipore Cat# DR1071 1:1000
SQSTM1 AB_10624872 Cell Signaling Technology Cat# 5114 1:1000
PINK1 AB_10127658 Novus Biologicals Cat# BC100-494 1:2000
PARK2 AB_2159920 Cell Signaling Technology Cat# 4211 1:1000
FUNDC1 AB_10609242 Santa Cruz Biotechnology Cat# sc-133597 1:500
BNIP3 AB_2259284 Cell Signaling Technology Cat# 3769S 1:1000
BNIP3L AB_2688036 Cell Signaling Technology Cat# 12396 1:1000
GABARAPL1 AB_2294415 Proteintech Group Cat# 11010-1-AP 1:1000
LC3B AB_915950 Cell Signaling Technology Cat# 2775 1:1000
DNM1L AB_10950498 Cell Signaling Technology Cat# 8570 1:1000
Caspase-3 AB_2341188 Cell Signaling Technology Cat# 9661 1:1000
HKII: Hexokinase II, OXPHOS: Oxidative phosphorylation, antibody cocktail (containing NADH: Ubiquinone oxidoreductase subunit B8 (NDUFB8), Succinate
dehydrogenase complex, subunit B (SDHB), ubiquinol cytochrome c reductase core protein 2 (UQCRC2), Mitochondrially encoded cytochrome c oxidase I (mt-COI),
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha (ATP5A)), PGC-1α: Proliferative activated receptor gamma, coactivator 1 alpha, NRF1: Nuclear
respiratory factor 1, ERRα: Estrogen Related Receptor alpha, Tfam: Mitochondrial transcription factor A, SQSTM1: Sequestosome 1, PINK1: PTEN-induced kinase 1,
PARK2: Parkin, FUNDC1: FUN14 domain-containing protein 1, BNIP3: BCL2/Adenovirus E1B 19 kDa protein-interacting protein 3, GABARAPL1: γ-aminobutiric
acid receptor-associated protein-like 1, LC3B: Microtubule associated protein 1A/1B-light chain 3 beta and DNM1L: Dynamin 1 Like.
https://doi.org/10.1371/journal.pone.0245155.t001
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measuring antioxidant capacity, 50 μl of the lysate was mixed with 950 μl ABTS•− solution at
37˚C for 5 min and absorbance was measured at 734 nm and compared to the absorbance of
an ABTS•− solution without sample. Absorbance was corrected for total protein content.
Intracellular ROS levels
As previously described [20], intracellular ROS levels were quantified using the 2’,7’-dichloro-
dihydrofluorescein diacetate (DCFH-DA)-assay. 72 h after cell seeding, cells were washed
twice with 150 μl HBSS, incubated for 1 h with 100 μl H2DCFH-DA (50 μM) and washed twice
again with 150 μl HBSS. After 24 h culture under the different conditions in duplicate as
described above, DCF was measured at λ excitation = 485 nm and λ emission = 525 nm and
corrected for total protein content.
Statistical analysis
Data are depicted as bar graphs indicating the mean and SEM as fold change compared to the
control. For each comparison, the D’agrostino and Pearson omnibus normality test was used
to test normality and subsequently either an unpaired t-test or Mann Whitney test was used
accordingly (GraphPad Software, La Jolla California USA). A p-value <0.05 was considered as
significantly different from the control group and was presented as follows: Ns: p>0.05, �p
�0.05, ��p�0.01, ���p�0.001. For each assay, three independent experiments were per-
formed in which each experimental condition contained 3–12 biological replicates. For subse-
quent data analysis, replicates were expressed as fold change compared to the control and were
subsequently pooled.
Results
Placental villous explants were exposed to hypoxia for up to 3 h since previous studies using
placental villous explants ex vivo showed that the viability of first and third-trimester tissue in
culture could only be maintained for 4 h [21]. Longer exposure times lead to pronounced tis-
sue deterioration and massive apoptosis of the trophoblasts in placental villous explants indi-
cating that, in this model, it is only suitable to study acute effects [22]. To study the effects of
long-term exposure to hypoxia and to determine if changes are trophoblast-specific, BeWo
cells were used.
Villous explant and BeWo viability
No significant differences were found for LDH activity between the control- and hypoxic-con-
ditioned villous explant medium indicating that viability of the placental villous explants was
comparable between the two conditions after 3 h of incubation. Furthermore, when BeWo
cells were cultured for 6 h, 24 h and 48 h under a normoxic or hypoxic condition, only at 48 h
a significant increase in LDH activity was observed in cell supernatant of BeWo cells exposed
to hypoxia compared to the control condition (S2 Fig). Since cell viability in the hypoxic con-
dition significantly decreased after 48 h culturing under hypoxia, compared to the control con-
dition, and therefore affecting the readouts of our study, 24 h exposure to hypoxia was used in
this study.
Increased oxidative stress levels in placental villous explants and BeWo
cells upon hypoxia
We first determined the impact of hypoxia (1% O2) on oxidative stress levels and known cellu-
lar antioxidant defense systems in placental villous explants as well as in cultured BeWo cells.
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As depicted in Fig 1, both the glutathione disulfide/glutathione (GSSG/GSH) ratio as well as
the trolox equivalent antioxidant capacity (TEAC) increased significantly in both placental vil-
lous explants and BeWo cells exposed to hypoxia (3 h and 24 h respectively). Also, although
placental villous explants exposed to hypoxia did not show alterations in mRNA abundance of
known antioxidant enzymes, in BeWo cells exposed to hypoxia mRNA transcript levels of cat-
alase 1 (Cat1) and mitochondrial manganese-dependent superoxide dismutase 2 (MnSOD2)
Fig 1. Increased oxidative stress levels in placentae and trophoblasts upon hypoxia. GSSG/GSH ratio (A), TEAC (B) and transcript levels of CAT1,
SOD1, XO and MnSOD2 (C) assessed in placental villous explants exposed to normoxia (control) or hypoxia for 3 h (n = 3) and GSSG/GSH ratio (D),
TEAC (E) and transcript levels of CAT1, SOD1, XO and MnSOD2 (F) assessed in trophoblasts exposed to hypoxia or normoxia (control) for 24h.
Intracellular ROS levels using DCFH-DA (G) and GSSG/GSH ratio (H) were assessed in trophoblasts exposed to normoxia (control), hypoxia or hypoxia
+ MitoQ (1, 4 or 8 μM) (DCFH-DA-assay: n = 6-12/experimental condition (n = 3 experiments), GSSG/GSH-assay: n = 2–6 experimental condition
(n = 3 experiments)). Data are presented as fold change compared to the control and as mean with SEM. �p� 0.05, ��p� 0.01 and ���p� 0.001. GSSG:
Oxidized glutathione, GSH: Reduced glutathione, TEAC: Trolox equivalent antioxidant capacity, Cat1: Catalase-1, SOD1: Superoxide dismutase 1, XO:
Xanthine oxidase, MnSOD2: Manganese-dependent superoxide dismutase and DCFH-DA: 2’,7’-Dichlorodihydrofluorescein diacetate.
https://doi.org/10.1371/journal.pone.0245155.g001
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significantly increased while transcript levels of superoxide dismutase 1 (SOD1) significantly
decreased (Fig 1A–1F).
As mitochondria are the main site for cellular oxygen consumption and the main source of
cellular ROS production, we next investigated whether or not hypoxia-induced changes in ROS
levels and antioxidant status originated from the mitochondria. Therefore, we used the mitochon-
drial-targeted antioxidant MitoQ in cultured BeWo cells during exposure to hypoxia. Intracellular
ROS levels, as well as oxidized glutathione levels increased more than two-fold in BeWo cells
exposed to hypoxia compared to normoxia-exposed BeWo cells, and MitoQ normalized both
hypoxia-induced increases in intracellular ROS formation and oxidized glutathione levels in
BeWo cells in a concentration-dependent manner (Fig 1G and 1H). In addition, as shown in S3
Fig, the antioxidant quercetin did not reduce hypoxia-induced intracellular ROS formation. Inter-
estingly, the combination of the lowest concentration of MitoQ (1 μM) and quercetin (3 μM) sig-
nificantly decreased hypoxia-induced intracellular ROS production and levels of oxidized
glutathione to levels similar as in the normoxia-exposed BeWo cells (Fig 1G and 1H).
In addition to these indicators of oxidative stress, mRNA transcript levels of tumor necrosis
factor alpha (TNF-α), interleukin 6 (IL-6) and interleukin 8 (IL-8) as well as the pro-apoptotic
mRNA transcript ratio of Bcl-2associated X protein / anti-apoptotic B-cell lymphoma 2 (BAX/
BCL-2) and protein levels of Cleaved Caspase-3 (17 + 15 KDa), were all significantly increased
in BeWo cells in response to 24 h of hypoxia but were unaltered in placental villous explants
after a 3 h exposure to hypoxia (S4A–S4E Fig).
Hypoxia-induced decrease in mitochondrial content in placental villous
explants and BeWo cells
Having established that hypoxia exposure in BeWo cells, results in mitochondrial ROS produc-
tion and considering the fact that ROS can damage mtDNA [23], we next assessed indices of
mitochondrial content in placental villous explants as well as in cultured BeWo cells exposed
to hypoxia. As shown in Fig 2, hypoxia-induced a profound reduction in mitochondrial con-
tent in both placental villous explants as well as in cultured BeWo cells. This was evidenced by
a reduction in mtDNA copy number and a decrease in the enzyme activity of citrate synthase
(CS) (Fig 2A–2D), two well-described indicators of mitochondrial content [24]. Moreover, the
combination MitoQ and quercetin, in concentrations that completely normalized hypoxia-
induced ROS formation (S3A and S3B Fig), ameliorated hypoxia-induced reductions in
mtDNA copy number in BeWo cells (Fig 2E). Subsequently, mitochondrial membrane poten-
tial (ΔCm) was assessed in BeWo cells stained with JC-10, after exposure to hypoxia. JC-10 is
selectively taken up into mitochondria and reversibly changes color from green to orange with
increased membrane potential. Hence, decreased mitochondrial depolarization was demon-
strated by a decrease in 570/515 fluorescence intensity ratios. Hypoxia-exposed BeWo cells
show a significantly lower mitochondrial membrane potential compare to the control condi-
tion (Fig 2F) which is in line with the increased proapoptotic status as indicated in S4D Fig.
Increased abundance and activity of glycolytic constituents in placental
cells in response to hypoxia
Next, we investigated whether the decrease in mitochondrial content observed in placental vil-
lous explants and in BeWo cells exposed to hypoxia was associated with changes in (mitochon-
drial- and non-mitochondrial) metabolic processes. Therefore, we assessed the abundance and
activity levels of key constituents of the ETC, fatty acid-β oxidation (FAO) and glycolysis.
mRNA abundance as well as enzymatic activity of β-hydroxyacyl-CoA dehydrogenase
(HADH), a key enzyme involved in mitochondrial FAO, were unaltered in response to
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hypoxia in both placental villous explants as well as in BeWo cells (S5A–S5D Fig). Interest-
ingly, while in placental villous explants exposed to hypoxia for 3 h transcript and protein
abundance of both nuclear- or mitochondrial-encoded sub-units of ETC complexes were unal-
tered (S6A–S6C Fig), protein levels of ubiquinol cytochrome c reductase core protein 2
Fig 2. Lower mitochondrial content in placental villous explants and trophoblasts upon hypoxia. mtDNA copy
number (A) and CS activity (B) assessed in placental villous explants exposed to hypoxia or normoxia (control) for 3 h
(n = 3 in duplicate) and mtDNA copy number (C) and CS activity (D) assessed in trophoblasts exposed to normoxia
(control) or hypoxia for 24 h. mtDNA copy number (E) was assessed in trophoblasts exposed to normoxia (control),
hypoxia, hypoxia + MitoQ (1, 4 or 8 μM), quercetin (3 μM) or MitoQ (1 μM) + quercetin (3 μM) for 24 h (n = 3-6/
experimental condition (n = 3 experiments)) and mitochondrial membrane potential changes (F) were measured with
JC-10 in BeWo cells exposed to hypoxia for 24 h (n = 3 experimental condition (3 experiments)). Data are presented as
fold change compared to the control and as mean with SEM. �p� 0.05, ��p� 0.01 and ���p� 0.001. mtDNA:
Mitochondrial DNA and CS: Citrate synthase.
https://doi.org/10.1371/journal.pone.0245155.g002
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(UQCRC2, complex III) as well as mRNA transcript levels of all investigated sub-units, includ-
ing mitochondrial-encoded COXII, were significantly decreased in BeWo cells after 24 h expo-
sure to hypoxia (S6D–S6F Fig).
When assessing activity levels of phosphofructokinase (PFK), a key enzyme involved in glycol-
ysis, we observed that hypoxia resulted in a significant increase in PFK activity in both placental
villous explants as well as in BeWo cells. Moreover, in BeWo cells, but not placental villous
explants, this was associated with a significant increase in protein and mRNA transcript levels of
hexokinase II (HKII) as well as transcript levels of the glucose transporter 1 (GLUT1) (Fig 3A–3F).
In line, exposing BeWo cells to hypoxia significantly increased L-lactate levels (Fig 3G).
Fig 3. Increased expression and activity of key glycolytic enzymes in placentae and trophoblasts upon hypoxia. PFK enzyme activity (A), HKII protein
level (B), mRNA expression levels of HKII and Glut-1 (C), assessed in placental villous explants exposed to normoxia (control) or hypoxia for 3 h (n = 3 in
duplicate (PFK assay) or (n = 3 (protein and mRNA)) and PFK enzyme activity (D), HKII protein level (E), mRNA expression levels of HKII and Glut-1
(F) and L-Lactate (G), assessed in trophoblasts exposed to normoxia (control) or hypoxia for 24 h (n = 3-6/experimental condition (n = 3 experiments)).
Representative immunoblots are shown and Western blots were corrected for total protein loading assessed by Ponceau S Staining with adjusted contrast
equally applied to the whole photograph. Black boxes around the representative pictures indicate that they were cut from the same Western blot. Data are
presented as fold change compared to the control and as mean with SEM. �p� 0.05 and ���p� 0.001. PFK: Phosphofructokinase, HKII: Hexokinase and
GLUT1: Glucose transporter 1.
https://doi.org/10.1371/journal.pone.0245155.g003
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Alterations in the molecular regulation of mitochondrial biogenesis in
BeWo cells upon hypoxia
Considering the reductions in mitochondrial content in placental cells upon exposure to hyp-
oxia, we next explored whether hypoxia affected the molecular regulation of mitochondrial
biogenesis by the PGC-1 signaling network. As shown in Fig 4, while no differences were
observed in the abundance of key regulators of mitochondrial biogenesis in placental villous
explants exposed to hypoxia for 3h (Fig 4A and 4B), protein levels of Tfam and ERRα were sig-
nificantly decreased in response to 24 h of hypoxia in BeWo cells. Furthermore, mRNA tran-
script levels of PGC-1β, NRF2α, Tfam, and ERRα were significantly decreased in BeWo cells
upon 24 h of exposure to hypoxia (Fig 4C and 4D).
Expression of key constituents of the mitophagy machinery is altered in
BeWo cells upon hypoxia
As mitochondrial content is determined by the balance between mitochondrial biogenesis and
breakdown through mitophagy (e.g. mitochondrial-specific autophagy), we next assessed the
Fig 4. Alterations in the molecular regulation of mitochondrial biogenesis in trophoblasts upon hypoxia. Protein levels of PGC-1α, NRF1,
Tfam and ERRα (A) and mRNA transcript levels of PGC-1α, PGC-1β, NRF1, NRF2α, Tfam, ERRα, PPARα and PPARδ (B) assessed in placental
villous explants exposed to normoxia (control) or hypoxia for 3 h (n = 3) and protein levels of PGC-1α, NRF1, Tfam and ERRα (C) and mRNA
transcript levels of PGC-1α, PGC-1β, NRF1, NRF2α, Tfam, ERRα, PPARα and PPARδ (D) assessed in trophoblasts exposed to normoxia (control)
or hypoxia for 24h (n = 3-6/experimental condition (n = 3 experiments)). Representative immunoblots are shown and Western blots were
corrected for total protein loading assessed by Ponceau S Staining with adjusted contrast equally applied to the whole photograph. Black boxes
around the representative pictures indicate that they were cut from the same Western blot. Data are presented as fold change compared to the
control and as mean with SEM. �p� 0.05 and ���p� 0.001. PGC-1α: Peroxisome proliferator-activated receptor gamma coactivator 1-alpha,
NRF1: Nuclear respiratory factor 1, Tfam: Mitochondrial transcription factor A, ERRα: Estrogen-related receptor alpha, PGC-1β: Peroxisome
proliferator-activated receptor gamma coactivator 1-beta, NRF2α: Nuclear respiratory factor 2 alpha, PPARα: Peroxisome proliferator-activated
receptor alpha, PPARδ: Peroxisome proliferator-activated receptor delta.
https://doi.org/10.1371/journal.pone.0245155.g004
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impact of hypoxia on key constituents of the mitophagy machinery in placental villous
explants and BeWo cells. As mitophagy requires several general autophagy-related proteins for
generating the autophagosomal membrane and priming the autophagosome to the mitochon-
dria, these proteins were studied as well.
All investigated constituents of the autophagy- (S7A and S7B Fig) and mitophagy machin-
ery (Fig 5A and 5B) were unaltered in placental villous explants exposed for 3h to hypoxia
compared to the control condition. In contrast, in BeWo cells exposed for 24 h to hypoxia,
mitophagy-related protein levels of PINK1 and FUNDC1, as well as mRNA transcript levels of
FUNDC1, were significantly decreased in response to hypoxia while both protein and mRNA
transcript levels of BNIP3 and BNIP3L were potently increased. In addition, while PARK2 pro-
tein levels were not affected in BeWo cells exposed to hypoxia, mRNA transcript levels of
PARK2 were significantly increased in response to hypoxia (Fig 5C and 5D). Also, in cultured
BeWo cells, 24 h of hypoxia resulted in a significant decrease in autophagy-associated LC3BI
Fig 5. Expression of key constituents of the mitophagy machinery is altered in trophoblasts upon hypoxia. Mitophagy-associated protein
levels of PINK1, PARK2, FUNDC1, BNIP3 and BNIP3L (A) and mRNA transcript levels of PINK1, PARK2, FUNDC1, BNIP3 and BNIP3L (B)
assessed in placental villous explants exposed to normoxia (control) or hypoxia for 3 h (n = 3) and mitophagy-associated protein levels of PINK1,
PARK2, FUNDC1, BNIP3 and BNIP3L (C) and mRNA transcript levels of PINK1, PARK2, FUNDC1, BNIP3 and BNIP3L (D) assessed in
trophoblasts exposed to normoxia (control) or hypoxia for 24 h (n = 3-6/experimental condition (n = 3 experiments)). Representative
immunoblots are shown and Western blots were corrected for total protein loading assessed by Ponceau S Staining with adjusted contrast equally
applied to the whole photograph. Black boxes around the representative pictures indicate that they were cut from the same Western blot. Data are
presented as fold change compared to the control and as mean with SEM. �p� 0.05, ��p� 0.01 and ���p� 0.001. PINK1: PTEN-induced kinase
1, PARK2: E3 ubiquitin-protein ligase Parkin, FUNDC1: FUN14 domain containing 1, BNIP3: BCL2/adenovirus E1B 19 kDa protein-interacting
protein 3 and BNIP3L: BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like.
https://doi.org/10.1371/journal.pone.0245155.g005
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and LC3BII protein levels while the ratio of LC3BII/LC3BI was significantly increased com-
pared to the normoxic condition. In addition, while both protein as well as mRNA levels of
GABARAPL were increased in response to hypoxia, protein levels of SQSTM1 were decreased
and its transcript levels increased upon hypoxia (S7C and S7D Fig). OPTN mRNA levels
increased 2-fold in response to hypoxia (S7D Fig).
Alterations of key constituents of mitochondrial fission and fusion in
BeWo cells upon hypoxia
As mitochondrial fission and fusion are key events in the processes of mitophagy and mito-
chondrial biogenesis and are essential in maintaining normal mitochondrial homeostasis,
mRNA and protein levels of mitochondrial fission and fusion proteins were investigated both
in placental villous explants as well as BeWo cells exposed to hypoxia. As depicted in Fig 6A
and 6B, no alterations were found in fission and fusion-related proteins and mRNA transcript
Fig 6. Alterations of key constituents of mitochondrial fission and fusion in trophoblasts upon hypoxia. Fission-
related protein levels of DNM1L (A), fission-related mRNA transcript levels of Fis-1 and DNM1L and fusion-related
mRNA transcript levels of Mfn1, Mfn2 and Opa1 (B) assessed in placentae exposed to normoxia (control) or hypoxia
for 3 h (n = 3) and fission-related protein levels of DNM1L (C), fission-related mRNA transcript levels of Fis-1 and
DNM1L and fusion-related mRNA transcript levels of Mfn1, Mfn2 and Opa1 (D) assessed in trophoblasts exposed to
normoxia (control) or hypoxia for 24 h (n = 3-6/experimental condition (n = 3 experiments)). Representative
immunoblots are shown and Western blots were corrected for total protein loading assessed by Ponceau S Staining
with adjusted contrast equally applied to the whole photograph. Black boxes around the representative pictures
indicate that they were cut from the same Western blot. Data are presented as fold change compared to the control and
as mean with SEM. ��p� 0.01 and ���p� 0.001. DNM1L: Dynamin-1-like protein, Fis-1: Fission 1 protein, Mfn1:
Mitofusin-1, Mfn2: Mitofusin-2 and Opa1: Optic atrophy protein 1.
https://doi.org/10.1371/journal.pone.0245155.g006
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levels in placental villous explants exposed for 3 h to hypoxia. In BeWo cells, fission related
protein levels of dynamin-1-like protein (DNM1L), a key protein involved in mitochondrial
fission [25], was significantly decreased after 24 h exposure to hypoxia. In addition, fission-
related mRNA transcript levels of fission 1 (Fis1) and DNM1L were significantly increased
after exposure to hypoxia, while mRNA expression of fusion-related transcript levels of mito-
fusin-1 (Mfn1) and Mfn2 was reduced in BeWo cells upon exposure to hypoxia (Fig 6C and
6D).
Discussion
In the current study, we show that hypoxia triggers placental oxidative stress, which likely
resulted from ROS formation and alterations in antioxidant status in trophoblasts. Moreover,
we show for the first time that, in BeWo cells exposed to hypoxia, mitochondria are a major
source of ROS and that hypoxia triggers a profound loss of mitochondrial content. Further-
more, in response to hypoxia, the abundance and activity of key constituents of glycolysis rap-
idly increased which, upon prolonged exposure to hypoxia in BeWo cells, was also associated
with significant reductions in the abundance of subunits of the electron transport chain and
changes in the expression of key regulatory molecules controlling mitochondrial biogenesis,
mitophagy and mitochondrial fission and fusion events.
Hypoxia-induced oxidative stress
The presence of placental oxidative stress and the link with PE pathophysiology is well-estab-
lished. Indeed, there is abundant evidence that placental oxidative stress triggers the release of
cytotoxic and vasoactive factors as well as pro-inflammatory cytokines into the maternal circu-
lation driving PE symptoms like maternal endothelial dysfunction and hypertension [2]. One
of the key triggers of placental oxidative stress that has been proposed in PE is hypoxia [5, 26].
In support of this notion, stabilization of hypoxia-inducible factor 1-alpha (HIF-1α) has been
reported in PE and hypoxia-exposed placentae [27–29]. Furthermore, both in hypoxia-
exposed trophoblasts as well as in a prenatal hypoxia rat model for PE increased oxidative
stress has been reported [5, 26, 30]. In line with these observations, the GSSG/GSH ratio (Fig
1A and 1D) and intracellular ROS levels in our study were significantly increased in placental
cells in response to hypoxia (Fig 1G and 1H). Furthermore, hypoxia markedly increased total
antioxidant capacity and oxidized GSH both in placental explants as well as BeWo cells in our
study (Fig 1A, 1B, 1D and 1E), which may be a compensatory response to increased oxidative
stress [31, 32]. The fact that mitochondrial superoxide concentration is tightly controlled by
the mitochondrial antioxidant MnSOD2 [33], combined with the notion that 24 h exposure of
BeWo cells to hypoxia in our study resulted in a 4-fold increase in transcript levels of MnSOD2
(Fig 1F) suggests mitochondria to be a significant source of ROS. In contrast to observations
in BeWo cells, despite the increased GSSG/GSH ratio in placental explants, no increase in
MnSOD2 was observed. This may be explained by the short exposure of placental explants to
hypoxia (3 h), compared to the 24 h exposure of BeWo cells to hypoxia. In agreement with the
notion that hypoxia-induced oxidative stress may originate from the mitochondria, the mito-
chondrial-targeted antioxidant MitoQ concentration-dependently reduced intracellular ROS
levels and lowered the GSSG/GSH ratio in BeWo cells during a 24 h exposure to hypoxia in
our study (Fig 1G and 1H). This is in line with previous finding by Aljunaidy et al. [26], who
showed not only normalization of oxidative stress levels by MitoQ in a hypoxic rat model of
reduced placental perfusion, but also protection against sex- and age-dependent alterations in
cardiac and vascular health of offspring later in life.
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Hypoxia-induced inflammation and apoptosis
In addition to leading to oxidative stress, 24 h exposure to hypoxia in our study resulted in
increased expression of inflammatory mediators in BeWo cells (S4C Fig) as well as an
increased BAX/BCL-2 mRNA expression ratio and increased protein levels of Cleaved Cas-
pase-3 (S4D and S4E Fig), indicative of activation of apoptosis, which is in line with previous
findings [34–36]. In agreement with previous studies, 3 h exposure to hypoxia, did not induce
a significant alteration in the expression of inflammatory cytokines and the induction of apo-
ptosis [37]. Furthermore, in response to hypoxia, our data showed decreased mitochondrial
membrane potential in BeWo cells (Fig 2F), which is well-known to trigger apoptosis [38] and
is also suggestive of a hypoxia-induced proapoptotic condition [39]. In line with this, it is well-
established that both the induction of inflammation as well as apoptosis of placental cells are
induced by hypoxia and are implicated in PE pathophysiology [40]. Indeed, women with PE
show higher plasma levels of TNF-α and elevated TNF-α protein and mRNA levels in their
placentae compared to normal pregnant women, [33]. Furthermore, TNF-α is known to be a
potent stimulus for endothelin 1 secretion, which is known to be a major vasoactive compound
released by the placenta under hypoxia, contributing to maternal hypertension [14, 41, 42].
With regard to apoptosis in our study, an increased BAX/BCL-2 ratio BeWo cells exposed to
hypoxia was also associated with an increased abundance of BNIP3 proteins (Fig 5C and 5D),
which act as an activator for hypoxia-induced cell apoptosis and autophagy by triggering the
BAX/Bak or LC-3/Beclin 1 signaling pathway [43, 44]. Several Bcl-2 family members including
BAX, have been shown to be directly regulated by a lack of oxygen via stabilization of HIF-1
[45].
Hypoxia-induced reduction in mitochondrial content
Interestingly, besides their traditional role in cellular energy metabolism, mitochondria are
also important mediators of oxidative stress, inflammation, and apoptosis. Moreover, evidence
is emerging that PE is associated with abnormalities at the levels of the mitochondrion in the
placenta [46, 47]. Indeed, besides alterations in placental mitochondrial content in PE [48],
several human studies showed significant reductions in adenosine triphosphate (ATP) levels
in PE placentae, which is suggestive of impaired mitochondrial functioning [49–51]. Indicative
of a role for hypoxia in mediating these changes, exposure of mice to lower oxygen (13%
instead of 21% O2) led to an overall reduction in placental mitochondrial oxidative capacity
[52] which could be beneficial to keep O2 transfer to the fetus constant [53]. This is in line with
our findings as we reported evidence for significant reductions in mitochondrial content in
both healthy placentae and BeWo cells exposed to hypoxia (Fig 2A–2E).
Hypoxia-induced shift from oxidative to glycolytic energy metabolism
Furthermore, expression of complex III of the ETC, which is the major source of mitochon-
drial production ROS in hypoxic conditions [54], as well as transcript levels of complex I and
IV including mitochondrial-encoded COXII were decreased in BeWo cells exposed to hypoxia
(S6D–S6F Fig), which is in concert with earlier studies [55, 56]. Despite a similar overall trend
that could be observed in placental explants exposed to hypoxia for 3 h, the relatively low
power and short exposure time, compared to our in vitro experiments may explain the less
pronounced alterations in gene and protein expression of the OXPHOS subunits (S6A–S6C
Fig). In addition, 24 h exposure to hypoxia in BeWo cells was associated with increased key
glycolytic enzyme activity and production of L-lactate in our study (Fig 3), which together
with the above-described data are suggestive for a shift from oxidative to glycolytic energy
metabolism. Exposing healthy placental explants to hypoxia for 3 h, significantly increased
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PFK activity, which the most prominent regulator enzyme in glycolysis. Expression of HKII
and GLUT, however, was not yet affected after 3 h exposure to hypoxia, indicating a dominant
role of PFK in the hypoxia-induced induction of glycolysis, which earlier was already found to
be hypoxia-sensitive as it is HIF-1-dependent [57]. In agreement with these findings, exposure
to low oxygen led to an increased trans-placental transfer of glucose and amino acids in mice
[58]. Moreover, oxidative stress during hypoxia is known to activate HIF which is known to
increase transcription of glycolytic enzymes and promote anaerobic glycolysis to maintain
ATP synthesis under low oxygen conditions [59]. In accordance with our results, showing
increased transcription of GLUT1 upon 24 h exposure to hypoxia (Fig 3F), GLUT1 is known
to be activated upon binding of HIF-1α to the hypoxia-responsive element in the GLUT-1 pro-
motor, which has been observed earlier in both hypoxia-exposed and PE placentae [5, 60]. Col-
lectively, this data in concert with available literature suggest that in response to hypoxia,
BeWo cells quickly develop mitochondrial-generated oxidative stress, display a subsequent
increase in glycolysis and by a decrease in expression of key components of the ETC. The
increased reliance on glycolysis found in cells of PE placentae or upon hypoxia may be a conse-
quence of the decreased mitochondrial content and impaired functioning of the ETC and thus
the capacity for producing ATP. This shift to anaerobic respiration may also be a protective
response of the placenta to the impaired placental perfusion in PE and so sparing O2 for the
growing fetus [53]. It is thus expected that increased glycolysis is more likely a consequence
than involved in the onset of PE.
Hypoxia-induced increase in mitophagy and fission
Reductions in oxidative respiration in hypoxic tissues have been associated with decreased
mitochondrial biogenesis [61–63]. In line with this and with decreased mitochondrial content
in placental cells in response to hypoxia that we observed, we also found significant reductions
in expression levels of key regulators of mitochondrial biogenesis (Fig 4C and 4D), which is in
accordance with recent studies [44]. The fact that we observed reduced mRNA levels of
nuclear- as well as mitochondrial-encoded OXPHOS subunits in BeWo cells exposed to hyp-
oxia for 24 h (S6E and S6F Fig) does suggest an impairment in the activity of mitochondrial
biogenesis. Moreover, the expression of OXPHOS genes is tightly controlled by the same key
regulators of mitochondrial biogenesis that we measured. More specifically, Tfam and ERRα,
have been convincingly demonstrated to control expression of mitochondrial-encoded and
nuclear-encoded OXPHOS genes respectively, which further strengthens our suggestion of
hypoxia-induced impairment of mitochondrial biogenesis. The discrepancy (as can be
observed in Fig 4) between changes in the protein and mRNA abundance of key regulators of
mitochondrial biogenesis in response to hypoxia in placental explants and BeWo cells
(although similar trends can be observed in both models) may be due to the duration of the
hypoxic incubation and the relative contribution of the different cell types present in these
models. Besides mitochondrial biogenesis, selective autophagy of mitochondria (i.e. mito-
phagy) is heavily involved in the regulation of mitochondrial content in cells. Enhanced mito-
phagy is suggested to be an adaptive response to reduce the levels of ROS and protect cell
integrity during hypoxia. It has previously been found that 1% O2 can lower mitochondrial
mass up to 75% through the initiation of the HIF1-dependent expression of BNIP3, a mito-
chondrial protein that competes with Bcl2 and thereby freeing beclin1 to trigger autophagy
[64]. In our study, BeWo cells exposed to hypoxia showed an increased abundance of recep-
tor-mediated mitophagy-related proteins BNIP3 and BNIP3L (Fig 5C and 5D), which is in line
with findings in previous studies [44, 65, 66]. In line with the literature, hypoxia-induced
increases in protein levels of BNIP3 and BNIP3L in BeWo cells were indeed associated with an
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increased abundance of general autophagy-related GABARAPL1 and an increased ratio of
LC3BII/LC3BI protein levels (S7C and S7D Fig), which are known to predispose mitochondria
for degradation [67, 68]. In addition, abundance of receptor-mediated mitophagy-related pro-
tein FUNDC1 was significantly decreased in BeWo cells in response to hypoxia (Fig 5C and
5D), which is in line with the hypoxia-mediated degradation of FUNDC1 as described by Chen
et al. [69]. Likely, these changes require some time to occur, as 3h of hypoxic incubation of pla-
cental explants did not reveal similar changes (Fig 5C and 5D). Collectively, these data suggest
that the molecular control of receptor-mediated mitophagy in placentae is altered upon hyp-
oxia, which may well contribute to the loss of mitochondrial content that we observed. In addi-
tion, mitochondrial biogenesis and mitophagy are highly integrated with mitochondrial fusion
and fission events. Increased mitochondrial fission has been implicated in the pathogenesis of
several diseases and is often linked with the increased presence of oxidative stress and apoptosis
[70–73]. In this regard, increased levels of fission-related Fis-1 and DMN1L transcripts and
decreased levels of fusion-related Mfn1 and Mfn2 transcripts found in our study (Fig 6C and
6D), indicate that the balance between fusion and fission may be tilted towards increased mito-
chondrial fission in response to hypoxia in our study. It is important to highlight that the
changes in the expression levels of these proteins/transcripts upon prolonged exposure to hyp-
oxia, have been shown to be associated with activation of mitophagy [74, 75], are merely sugges-
tive of changes in the molecular control of mitophagy. As a follow-up step, in order to confirm
active mitophagy in these cells in response to hypoxia, it is suggested, to visualize mitochondria
with electron microscopy to further morphometrically identify this process in more detail.
Collectively, with regard to the time-course of hypoxia-induced changes, our data show
that oxidative stress in cells of the placenta develops rapidly in response to hypoxia, which is
associated with profound reductions in mitochondrial content and increased activity of glyco-
lytic enzymes. Alterations in the molecular mechanisms controlling mitochondrial content
and function (mitochondrial biogenesis vs mitophagy), however, only become apparent after
prolonged exposure to hypoxia (24h).
Interestingly, although MitoQ and quercetin together initiated complete normalization of
intracellular ROS formation during hypoxia, MitoQ alone did not completely prevent intracellular
ROS formation suggesting that other cellular ROS-generating systems contribute to hypoxia-
induced oxidative stress in placental cells. In agreement with this, xanthine oxidase has been
shown to be implicated in PE pathophysiology and has been suggested to contribute to (hypoxia-
induced) placental oxidative stress [76, 77]. To further investigate whether these anti-oxidants
may confer protection in villous explants ex vivo, it is suggested that this intervention regime is
performed in (perfused) placental explants to further consolidate our findings in BeWo cells.
In conclusion, our results show hypoxia-induced abnormalities at the level of the mitochon-
drion and the molecular pathways controlling mitochondrial content and function in placen-
tae and oxidative stress, which may contribute to PE pathogenesis or other hypoxia-related
pregnancy disorders like intrauterine growth restriction (IUGR). Although the concept of hyp-
oxia-induced mitochondrial abnormalities in cells of the placenta is not new [78], our study is
the first to show that hypoxia-induced oxidative stress mainly originates from the mitochon-
dria and is unique in comprehensively assessing not only indices of mitochondrial content but
also multiple constituents of mitochondrial biogenesis and mitophagy in cells of the placenta
in response to hypoxia.
Supporting information
S1 Fig. Blot/Gel image data of all conditions including Ponceau S staining. No significant
differences were found for LDH activity between the control- and hypoxic-conditioned villous
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explant medium indicating that viability of the placental villous explants was comparable
between the two conditions after 3 h of incubation. Furthermore, when BeWo cells were cul-
tured for 6 h, 24 h and 48 h under a normoxic or hypoxic condition, only at 48 h a significant
increase in LDH activity was observed in cell supernatant of BeWo cells exposed to hypoxia
compared to the control condition (S2 Fig). Since cell viability in the hypoxic condition signifi-
cantly decreased after 48 h culturing under hypoxia, compared to the control condition, and
therefore affecting the readouts of our study, 24 h exposure to hypoxia was used in this study.
(PDF)
S2 Fig. Villous explant and BeWo viability. LDH activity between the control- and hypoxic-
conditioned villous explant after 3 h of incubation (A) and in BeWo cells after 6 h, 24 h and 48
h incubation (B). To confirm whether mitochondria are a significant source for ROS in pla-
centae upon hypoxia, the effect of the mitochondrially targeted antioxidant MitoQ and the sys-
temically acting antioxidant quercetin on ROS formation and oxidative status was tested.
Intracellular ROS levels increased more than two-fold in trophoblasts exposed for 24 h to hyp-
oxia compared to normoxia-exposed trophoblasts (S3A Fig). Moreover, the mitochondrially
targeted antioxidant MitoQ (4 and 8 μM) ameliorated hypoxia-induced intracellular ROS for-
mation in trophoblasts in a concentration-dependent manner. The systemically acting antioxi-
dant quercetin (3 μM), did not induced significant reductions in intracellular ROS formation
during exposure to hypoxia. Interestingly, the combination of the lowest concentration of
MitoQ (1 μM) and quercetin (3 μM) significantly decreased intracellular ROS production
upon 24 h exposure to hypoxia and was the only condition that was not significantly different
from the normoxic condition (S3A Fig). In agreement, the hypoxia-induced increase of the
GSSG/GSH ratio, could be normalized by MitoQ (4 and 8 μM) and quercetin (3 μM), but were
still significantly different compared to the control condition (S3B Fig). Interestingly, the com-
bination of the lowest concentration of MitoQ (1 μM) and quercetin (3 μM), normalized the
GSSG/GSH ratio during exposure to hypoxia (S3B Fig).
(TIF)
S3 Fig. Antioxidant intervention prevented hypoxia-induced oxidative stress in tropho-
blasts. Intracellular ROS levels using DCFH-DA (A) and GSSG/GSH ratio (B) were assessed
in trophoblasts exposed to normoxia (control), hypoxia, hypoxia + MitoQ (1, 4 or 8 μM), quer-
cetin (3 μM) or MitoQ (1 μM) + quercetin (3 μM) for 3 h (DCFH-DA-assay: n = 6-12/experi-
mental condition (n = 3 experiments) and GSSG/GSH-assay: n = 6, 2 and 2/experimental
condition (n = 3 experiments)). Data are presented as fold change compared to the control
and as mean with SEM. �p� 0.05, ��p� 0.01 and ���p� 0.001. DCFH-DA: 2’,7’-Dichlorodi-
hydrofluorescein diacetate and GSSG: Glutathione disulfide, GSH: Glutathione. While placen-
tae exposed to hypoxia did not show alterations in proinflammatory and apoptotic-related
mRNA transcripts, mRNA levels of tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6) and
interleukin 8 (IL-8) as well as the pro-apoptotic ratio of Bcl-2associated X protein / anti-apo-
ptotic B-cell lymphoma 2 (BAX/BCL-2) and protein levels of Cleaved Caspase-3 (17 + 15
KDa), were significantly increased in trophoblasts exposed for 24 h to hypoxia compared to
the control condition (S4C–S4E Fig).
(TIF)
S4 Fig. Increased inflammation and apoptosis in trophoblasts upon hypoxia. mRNA tran-
script levels of TNF-α, IL-6 and IL-8 (A) and ratio of BAX/BCL2 transcript levels (B) assessed
in placental villous explants exposed to hypoxia or normoxia (control) for 3 h (n = 3) and
mRNA transcript levels of TNF-α, IL-6 and IL-8 (C) and ratio of BAX/BCL2 transcript levels
(D) and protein levels of Cleaved Caspase-3 (17 + 15 KDa) (E) assessed in trophoblasts
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exposed to normoxia (control) or hypoxia for 24 h (n = 3-6/experimental condition (n = 3
experiments)). Data are presented as fold change compared to the control and as mean with
SEM. �p� 0.05, ��p� 0.01 and ���p� 0.001. TNF-α: Tumor necrosis factor α, IL-6: Interleu-
kin 6, IL-8: Interleukin 8, BAX: pro-apoptotic Bcl-2-associated X protein and BCL: anti-apo-
ptotic B-cell lymphoma 2. In contrast to the increased reliance on glycolysis in placental cells
upon hypoxia, no differences were observed in activity and mRNA expression levels of the
rate-limiting enzyme HADH of the FAO pathway in both placental villous explants and tro-
phoblasts exposed to hypoxia compared to the control group (S5A–S5D Fig).
(TIF)
S5 Fig. Mitochondrial FAO unaltered in placental cells upon hypoxia. HADH enzyme activ-
ity (A) and mRNA transcript levels of HADH (B) assessed in placental villous explants exposed
to hypoxia or normoxia (control) for 3 h (n = 3) and HADH enzyme activity (C) and mRNA
transcript levels of HADH (D) assessed in trophoblasts exposed to normoxia (control) or hyp-
oxia for 24 h (n = 3, 6 and 6/experimental condition (n = 3 experiments)). Data are presented
as fold change compared to the control and as mean with SEM. HADH: 3-hydroxyacyl-CoA
dehydrogenase. Protein levels of nuclear-encoded sub-units of the ETC including Ndufb8,
Sdhb, UQCR2 and ATP5A of respectively complex I, II, III and V, were not affected in placen-
tal villous explants exposed for 3 h to hypoxia (S6A Fig). Also, related mRNA transcript levels
of Ndufb3, Cycl-1, COXIV and COXII of respectively complex I, III, IV and IV, were not
affected in placental villous explants after exposure to hypoxia (S6B Fig). Protein levels of
UQCRC2 (complex III) as well as mRNA transcript levels of all investigated sub-units includ-
ing mitochondrial encoded COXII were significantly decreased in trophoblasts upon 24h
exposure to hypoxia (S6D–S6F Fig).
(TIF)
S6 Fig. Alterations in nuclear-encoded OXPHOS sub-units in trophoblasts upon hypoxia.
Protein levels of nuclear-encoded OXPHOS sub-units (Ndufb8, Sdhb, UQCRC2 and ATP5A
respectively Complex I, II, III and V) (A) and mRNA transcript levels of nuclear-encoded
OXPHOS sub-units (Ndufb, Cycl-1, COXIV and COXII respectively Complex I, III, IV and IV)
(B) assessed in placental villous explants exposed to normoxia (control) or hypoxia for 3 h
(n = 3) and protein levels of nuclear-encoded OXPHOS sub-units (Ndufb8, Sdhb, UQCRC2
and ATP5A respectively Complex I, II, III and V) (C) and mRNA transcript levels of nuclear-
encoded OXPHOS sub-units (Ndufb, Cycl-1, COXIV and COXII respectively Complex I, III,
IV and IV) (D) assessed in trophoblasts exposed to normoxia (control) or hypoxia for 24 h
(n = 3-6/experimental condition (n = 3 experiments)). Representative immunoblots are shown
and Western blots were corrected for total protein loading assessed by Ponceau S Staining
with adjusted contrast equally applied to the whole photograph. Black boxes around the repre-
sentative pictures indicate that they were cut from the same Western blot. Data are presented
as fold change compared to the control and as mean with SEM. Ndufb3: NADH dehydroge-
nase [ubiquinone] 1 beta subcomplex subunit 3, Sdhb: Succinate dehydrogenase [ubiquinone]
iron-sulfur subunit, UQCRC2: Cytochrome b-c1 complex subunit 2, ATP5A: ATP synthase F1
subunit alpha, Cyc1: Cytochrome C1, COXIV: Cytochrome c oxidase subunit IV and COXII:
Cytochrome c oxidase subunit II. All investigated constituents of the autophagy in our study
were unaltered in placental villous explants exposed for 3h to hypoxia compared to the control
condition (S7A and S7B Fig). In cultured trophoblasts, 24 h hypoxia resulted in a significant
decrease in autophagy-associated LC3BI and LC3BII protein levels while the ratio of LC3BI/
LC3BII was significantly increased compared to the normoxic condition. In addition, while
both protein as well as mRNA levels of GABA Type A Receptor Associated Protein Like 1
(GABARAPL1) were increased in response to hypoxia, protein levels of SQSTM1 were
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decreased and its transcript levels increased upon hypoxia (S7C and S7D Fig). OPTN mRNA
levels increased 2-fold in response to hypoxia (S7D Fig).
(TIF)
S7 Fig. Expression of key constituents of the autophagy machinery is altered in trophoblast
upon hypoxia. Autophagy-associated protein levels of SQSTM1, GABARAPL1, LC3BI,
LC3BII and LC3BII / LC3BI ratio (A) and mRNA transcript levels of SQSTM1, GABARAPL1,
OPTN and LC3B (B) assessed in placental villous explants exposed to normoxia (control) or
hypoxia for 3 h (n = 3) and autophagy-associated protein levels of SQSTM1, GABARAPL1,
LC3BI and LC3BII (C) and mRNA transcript levels of SQSTM1, GABARAPL1, OPTN and
MAP1LC3A/B (D) assessed in trophoblasts exposed to normoxia (control) or hypoxia for 24 h
(n = 3-6/experimental condition (n = 3 experiments)). Representative immunoblots are shown
and Western blots were corrected for total protein loading assessed by Ponceau S Staining
with adjusted contrast equally applied to the whole photograph. Black boxes around the repre-
sentative pictures indicate that they were cut from the same Western blot. Data are presented
as fold change compared to the control and as mean with SEM. �p� 0.05 and ���p� 0.001.
SQSTM1: Sequestosome 1, GABARAPL1: GABA Type A Receptor Associated Protein Like 1,
LC3B: Microtubule-associated protein 1 light chain 3 beta, OPTN: Optineurin and LC3A:
Microtubule-associated protein 1 light chain 3 alpha.
(TIF)
S1 Table. Primers used for qPCR.
(DOCX)
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